Bibliographical noteFunding Information:
The PharmAccess African Studies to Evaluate Resistance is an initiative of PharmAccess Foundation, supported by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454). The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a programme of amfAR, The Foundation for AIDS Research, with major support provided by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454), and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in the study design, data collection, data analysis, data interpretation, decision to publish or writing of the report. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above.
Through the LAASER programme, PASER and TASER receive financial support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, PharmAccess Foundation, TREAT Asia (a programme of amfAR, The Foundation for AIDS research) and International Civil Society Support. PASER-M is coordinated by PharmAccess Foundation, in collaboration with the Amsterdam Institute for Global Health and Development (AIGHD) and the Virology Department at the University Medical Center Utrecht, The Netherlands. TASER-M is coordinated by TREAT Asia and its statistical and data management centre is the National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales in Sydney, Australia.
All Science Journal Classification (ASJC) codes